How should patients with indirect traumatic optic neuropathy be treated?

Journal of Neuro-Ophthalmology

Volumn 31, Issue 2, 2011, Pages 169-174

  Volpe, Nicholas J ^a   Levin, Leonard A ^b,c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BRIMONIDINE; CORTICOSTEROID; MEMANTINE; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENT; RILUZOLE; STEROID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AXONAL INJURY; BLOOD FLOW; CELL SURVIVAL; DRUG MEGADOSE; EYE MOVEMENT; GLAUCOMA; HEAD INJURY; HUMAN; INFLAMMATION; ISCHEMIC OPTIC NEUROPATHY; LIPID PEROXIDATION; LOADING DRUG DOSE; MORTALITY; MULTICENTER STUDY (TOPIC); NERVE DECOMPRESSION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; OPTIC NEURITIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SPINAL CORD INJURY; TRAUMATIC OPTIC NEUROPATHY; VISION; VISUAL IMPAIRMENT;

ANIMALS; DECOMPRESSION, SURGICAL; HUMANS; OPTIC NERVE INJURIES; STEROIDS;

EID: 79958067874     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e31821c9b11     Document Type: Article

References (29)

1. Atkins EJ, Newman NJ, Biousse V. Post-traumatic visual loss. Rev Neurol Dis. 2008;5:73-81. (Pubitemid 351947618)
2. Yu Wai Man P, Griffiths PG. Surgery for traumatic optic neuropathy. Cochrane Database Syst Rev. 2005, CD005024.
3. Yu-Wai-Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database Syst Rev. 2007, CD006032.
4. Weichel ED, Colyer MH, Ludlow SE, Bower KS, Eiseman AS. Combat ocular trauma visual outcomes during operations iraqi and enduring freedom. Ophthalmology. 2008;115: 2235-2245.
5. Lessell S. Indirect optic nerve trauma. Arch Ophthalmol. 1989;107:382-386. (Pubitemid 19078281)
6. Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999; 106: 1268-1277. (Pubitemid 30191468)
7. Joseph MP, Lessell S, Rizzo J, Momose KJ. Extracranial optic nerve decompression for traumatic optic neuropathy. Arch Ophthalmol. 1990;108:1091-1093. (Pubitemid 20265266)
8. Cook MW, Levin LA, Joseph MP, Pinczower EF. Traumatic optic neuropathy. A meta-analysis. Arch Otolaryngol Head Neck Surg. 1996. 122:389-392.
9. Seiff SR. High dose corticosteroids for treatment of vision loss due to indirect injury to the optic nerve. Ophthalmic Surg. 1990;21:389-395. (Pubitemid 20245385)
10. Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ. Treatment of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol. 1990;110:665-669.
11. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322: 1405-1411. (Pubitemid 20152525)
12. Steinsapir KD, Goldberg RA, Sinha S, Hovda DA. Methylprednisolone exacerbates axonal loss following optic nerve trauma in rats. Restor Neurol Neurosci. 2000; 17:157-163. (Pubitemid 32537935)
13. Steinsapir KD. Treatment of traumatic optic neuropathy with high-dose corticosteroid. J Neuroophthalmol. 2006;26: 65-67. (Pubitemid 44502765)
14. Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebocontrolled trial. Lancet. 2004;364:1321-1328.
15. Rajiniganth MG, Gupta AK, Gupta A, Bapuraj JR. Traumatic optic neuropathy: visual outcome following combined therapy protocol. Arch Otolaryngol Head Neck Surg. 2003; 129:1203-1206. (Pubitemid 37433157)
16. Mahapatra AK, Tandon DA. Traumatic optic neuropathy in children: a prospective study. Pediatr Neurosurg. 1993;19: 34-39. (Pubitemid 23129047)
17. Li H, Zhou B, Shi J, Cheng L, Wen W, Xu G. Treatment of traumatic optic neuropathy: our experience of endoscopic optic nerve decompression. J Laryngol Otol. 2008;122: 1325-1329.
18. Li KK, Teknos TN, Lai A, Lauretano AM, Joseph MP. Traumatic optic neuropathy: result in 45 consecutive surgically treated patients. Otolaryngol Head Neck Surg. 1999;120:5-11. (Pubitemid 29036312)
19. Wang DH, Zheng CQ, Qian J, Barr JJ, Anderson AG Jr. Endoscopic optic nerve decompression for the treatment of traumatic optic nerve neuropathy. ORL J Otorhinolaryngol Relat Spec. 2008;70:130-133. (Pubitemid 351535833)
20. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273: 625-632.
21. Beck RW, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DI. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992;326: 581-588.
22. Wilhelm B, Ludtke H, Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute nonarteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol. 2006;244: 551-558.
23. Newman NJ, Biousse V, David R, Bhatti MT, Hamilton SR, Farris BK. Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol. 2005;140:407-415.
24. Ohlsson M, Westerlund U, Langmoen IA, Svensson M. Methylprednisolone treatment does not influence axonal regeneration or degeneration following optic nerve injury in the adult rat. J Neuro-Ophthalmol. 2004;24:11-18. (Pubitemid 38381218)
25. Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R, Bähr M. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci. 2003;23:6993-7000. (Pubitemid 36975865)
26. Danesh-Meyer HV, Levin LA. Neuroprotection: extrapolating from neurologic diseases to the eye. Am J Ophthalmol. 2009;148:186-191.
27. Danesh-Meyer HV, Papchenko T, Savino PJ, Law A, Evans J, Gamble GD. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci. 2008;49:1879-1885.
28. Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM, Fitzke FW. real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A. 2004;101:13352-13356. (Pubitemid 39209669)
29. Kanamori A, Catrinescu MM, Traistaru M, Beaubien R, Levin LA. In vivo imaging of retinal ganglion cell axons within the nerve fiber layer. Invest Ophthalmol Vis Sci. 2010;51:2011-2018.